Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs.
Rosaria Di LorenzoAnita IorioMargherita PinelliFederica MagariniMattia MarchiAndrea SacchettiChiara CalogeroGian Maria GaleazziPaola FerriSergio RovestiAlessandro MinariniPublished in: Neuropsychiatric disease and treatment (2022)
HAL-D, PP1M and PP3M 1-year treatments were similarly effective in preventing relapses and improving quality of life and health satisfaction. All discontinuations in the new 3-monthly antipsychotic treatment were caused by patient refusal to continue it.